Support of GE Healthcare to quicken CBMG’s Cell Therapy Manufacturing

CBMG is Cellular Biomedicine Group which develops proprietary cell therapies for the treatment of cancer and degenerativ...

January 22, 2018 | Monday | News
Exact therapy for rare genetic disorders of obesity

WuXi NextCODE, the emerging global standard platform for genomic data, announced a partnership with Rhythm Pharmaceutica...

January 11, 2018 | Thursday | News
Eisai expands its oral solid dose production facility

Eisai Co., Ltd. announced that its Chinese subsidiary, Eisai China Inc. (ECI) has completed construction of a new oral s...

January 11, 2018 | Thursday | News
Clinical trial using BioAtla's Conditionally Active Biologics for cancer treatment

BioAtla, a global biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein therap...

January 9, 2018 | Tuesday | News
Cantargia Receives Patent Approval in China

Cantargia is a biotech company that is developing antibody-based treatments for life-threatening diseases. The company'...

January 5, 2018 | Friday | News
China-based HaploX Biotechnology closes a $32 million Series-A plus financing round

China-based company, HaploX that focuses on precision medicine and genetic data has closed a $32 million Series A-plus f...

January 4, 2018 | Thursday | News
Inovio pharmaceuticals, Apollobio to co-develop and commercialize cervical cancer drug

Inovio Pharmaceuticals,  today announced that it entered an amended agreement providing ApolloBio Corporation ...

January 3, 2018 | Wednesday | News
Sansure Biotech secures $77M led by Lilly Asia

Hunan Province-based biotechnology firm Sansure Biotech has raised $77 million from a group of investors led by Lilly As...

January 3, 2018 | Wednesday | News
China brings out the largest human genome project

In a move towards documenting the genetic makeup of one lakh people to help generate the precision medicines for the fut...

December 29, 2017 | Friday | News
vTv Therapuetics inks deal with China's Hangzhou Zhongmei Huadong Pharmaceutical

vTv Therapeutics, a US-based a clinical-stage biopharmaceutical company has inked a licensing deal with China’s Ha...

December 22, 2017 | Friday | News
Partnership between Janssen and Legend Biotech for CAR-T Anti-Cancer Therapy

Announcement is done by Janssen Pharmaceutical Company of Johnson & Johnson that it has entered into a worldwide col...

December 22, 2017 | Friday | News
Jacobson Pharma to tap biosimilars market

Jacobson Medical and Joyful Ascent Limited, subsidiaries of Jacobson Pharma Corporation Limited have entered into a Lice...

December 21, 2017 | Thursday | News
US researchers work towards improving healthcare in China

A group of researchers at Harvard University have designed a system that aligns financial incentives for physicians and ...

December 20, 2017 | Wednesday | News
Impulse Dynamics' Optimizer Receives nod of CFDA

Dr. Simos Kedikoglou, CEO of Impulse Dynamics announced about the approval of Impulse Dynamics' Optimizer system by Chin...

December 19, 2017 | Tuesday | News
Gilead’s patent for ‘Hepatitis C’ faces legal challenges

Medecins Sans Frontieres (MSF) is an international, independent medical humanitarian organization, MSF has filed a lega...

December 18, 2017 | Monday | Regulatory
Scientists in China develop novel photo thermal therapy

A team of scientists at China are working with nanorods made of bismuth sulfide to kill tumor cells with heat when they ...

December 13, 2017 | Wednesday | News
I-Mab signs $120 M deal with MorphoSys

German biotech MorphoSys has collaborated with Shanghai-based I-Mab Biopharma granting the latter an exclusive regional ...

December 5, 2017 | Tuesday | News
Destiny Pharma collaborates with Chinese firm

UK-based biotech Destiny Pharma has entered into a collaboration with CMS, a subsidiary of China Medical System. Th...

December 4, 2017 | Monday | News